Skip to content

PHARMACIE NAIM

Active
Private limited companyfounded 1987active for 38 yearsRue Ferdinand Nicolay 677, 4420 Saint-Nicolas, BelgiumKBO/BCE: BE 0432.596.739
Summary

PHARMACIE NAIM has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €189,212 and a net result of -€16,289. Equity has been shrinking by about 3.1% per year since 2018. Its solvency ranks better than 54% of 9,850 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 19-11-1987 Normal situation
Activity
Wholesale of pharmaceutical and medical goods NACE 46460and 2 others
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.031.702.810 4420 Saint-Nicolas, since 11-12-1987
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board
Shareholders
  • Racha NAIM· score 912025 annual accounts of Racha NAIM

Financial position

88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€66,478
▲ 10.3%
Turnover
≈ €260,000
estimated
Loss
€16,289
▲ 818%
Equity
€189,212
▼ 7.9%
Total assets
€403,450
▲ 31.9%
Employees on 31-12-2025
2
▲ 100%
Score breakdownraises riskLoss of €16,289, the second in a row (financial year 2025)lowers riskFounded in 1987Figures for financial year 2025 (filed on 04-06-2026)Equity €189,212 (46.9% of total assets)Show the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 42% of micro companies in wholesale trade (NACE 46)
Financial strength · tick: 2024
Average
Solvency 72-20
equity 46.9% of total assets
Liquidity 56-17
short-term debt 18.5% · cash 8.7%
Profitability 23-45
return on assets -4.0%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,900 companies, NACE 46, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.2%▲ +0.1 percentage points vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: < 0.1%▼ -0.2 percentage points vs 05-2025lowest value 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.2%▲ +0.2 percentage points vs 06-2026highest value 08-2026: 0.2%● unchanged vs 07-2026highest value 09-2026: 0.2%● unchanged vs 08-2026highest value 10-2026: 0.2%● unchanged vs 09-2026highest value 11-2026: 0.2%● unchanged vs 10-2026highest value
Credit of up to €16,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.51 (3.37 in 2024), above the usual 1.5. Short-term debt is 18.5% and cash 8.7% of total assets. However, 53.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 55% of them on solvency, 61% on liquidity, 23% on profitability and 28% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Founded in 1987
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Loss of €16,289, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 04-06-2026)
NBB · annual accounts
lowers risk · Equity €189,212 (46.9% of total assets)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€16,289
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
58 days early
2024
80 days early
2023
78 days early
2022
76 days early
2021
82 days early
2020
166 days late
2019
52 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 37 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 15 May (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: 4 loss-making years in a rowloss in financial year 2025 -€16,289 View
  • Caution: Lower net result than 83% of companies in wholesale tradesector median €26,853 · 9,829 companies -€16,289 View
  • Caution: A director leftlatest change 01-01-2026 · 1 in office 1 left View
  • Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

Recent changes

  1. · Gazette deed Resignation: Roel Fiey Management BV (director)Permanent representatives: Roel Fiey and NAIM RACHA
  2. · Gazette deed 2 directors appointed, 2 directors resigningChanges of role: ROEL FIEY MANAGEMENT (director) and RACHA NAIM (director) · Permanent representatives: FIEY Roel and NAIM Racha
  3. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as PHARMACIE NAIM: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €389,000 and €807,000, founded between 1984 and 1993.

CompanyTotal assetsGross margin
PHARMACIE NAIM Saint-Nicolas€403,450€66,478
ENVEDERM Lievegem€558,966€63,905
SERCOLAB Antwerpen€389,069€115,727
NAQI BELGIUM Brussel€409,764€107,930
PHARMACIE D'ANDENELLE Andenne€675,423€101,294
CANTAERT MEDICAL Merelbeke-Melle€521,202€120,729
EURO MEDICAL Burdinne€807,168€108,719
Full comparison

Key facts about PHARMACIE NAIM

What is the company number of PHARMACIE NAIM?
The company number of PHARMACIE NAIM is 0432.596.739. The VAT number is the same number with BE in front: BE 0432.596.739.
Where is PHARMACIE NAIM based?
The registered office is at Rue Ferdinand Nicolay 677, 4420 Saint-Nicolas.Company details
What does PHARMACIE NAIM do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of PHARMACIE NAIM?
The legal form of PHARMACIE NAIM is Private limited company (BV).
When was PHARMACIE NAIM founded?
PHARMACIE NAIM was founded on 19-11-1987.
Is PHARMACIE NAIM still active?
Yes, PHARMACIE NAIM is an active enterprise in the KBO register.
How many employees does PHARMACIE NAIM have?
PHARMACIE NAIM had an average of 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMACIE NAIM fall under?
In its 2025 annual accounts, PHARMACIE NAIM states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of PHARMACIE NAIM?
The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €66,478 and 33 comparable companies (NACE 464). It probably lies between €140,000 and €360,000.
Is PHARMACIE NAIM profitable?
In financial year 2025, PHARMACIE NAIM made a loss of €16,289.
Where can I find the annual accounts of PHARMACIE NAIM?
PHARMACIE NAIM filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE NAIM due?
PHARMACIE NAIM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.